Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 49 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. The SChISM study: Circulating cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors
    Linh Nguyen Phuong, Frederic Fina, Laurent Greillier +10
    HALPreprintCC BY-NC-SA 4.0Full textOncologyPharmacology & toxicologyHAL
  2. Post-Transcriptional Control of LINE-1 Retrotransposition by Cellular Host Factors in Somatic Cells
    Javier G Pizarro, Gaël Cristofari
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BY 4.0Full text89 citedOncologyHAL
  3. Exercise oncology and tumor sterol metabolism: An emerging mechanistic frontier
    Marc Poirot, Philippe de Médina, Sandrine Silvente-Poirot
    Journal of Sport and Health SciencePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPharmacology & toxicologyHAL
  4. Addressing connectomic constraints in early practice of awake-guided neurosurgery: a four-year prospective case-matched analysis
    Sam Ng, Andrea Otamendi-Lopez, Basile Martin +5
    Acta NeurochirurgicaPeer-reviewedCC BY-NC-ND 4.0Full textOncologySurgery & anaesthesiaHAL
  5. SCD1 inhibition promotes lipid peroxidation and enhances anti-PD-1 response in triple-negative breast cancer
    Quentin Herrera Garfia, Aurélien Azam, Eric Bonneil +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  6. The CXCL12/CXCR4 axis in breast cancer-associated fibroblasts: a transcriptome analysis and systematic literature review
    Sergey Vladimirov, David Sergeevichev, Maria Bogachek +4
    Frontiers in Bioengineering and BiotechnologyPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  7. Distinct spatial immune architectures in tumor and tumor-adjacent tissues of early-stage non-small cell lung cancer
    Isabella Polic, Claudio Arrechedera, Jared K. Slone +22
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  8. Longitudinal peripheral immune dynamics during anti-programmed cell death 1 neoadjuvant therapy in esophageal squamous cell carcinoma
    Linpeng Li, Lingwen Meng, Xinru Chen +11
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  9. From algorithm performance to clinical value in AI-assisted skin cancer diagnostics
    Lennart Ocker-Serger, Elisabeth Livingstone, Georg Lodde +4
    Frontiers in Digital HealthPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  10. Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinoma
    Ondřej Fiala, Jan Králíček, Jindřich Kopecký +18
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  11. Treating a systemic disease as a local one: failure points of current pancreatic cancer management and a multimodal, biology-guided framework for redesign
    Patrick E. Sewell
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  12. Risk factors associated with colorectal adenomas and the formulation of prediction models
    Haoming Yu, Zongyu Qiu, Wenyao Sui +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  13. Clinical outcomes and prognostic factors in pediatric acute myeloid leukemia with monocytic differentiation: a single-center cohort study from Egypt
    Tarek Ahmed Abdelrehim Ahmed, Mahmoud Hammad, Sonya Soliman +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  14. Natural history and literature review of primary intracranial CIC-rearranged sarcomas: case report
    Arissa Khan, Maryam Khan, Abigail Bowser +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  15. Beyond binary: a novel anatomical-geographical-biological framework for perineural invasion risk stratification in oral squamous cell carcinoma – a proof-of-concept study
    Shanthi Velusamy, Prajwal Dange, Karthik N. Rao +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  16. Development and validation of a nomogram for predicting chest drainage after CT-guided percutaneous lung biopsy: a multicenter retrospective study
    Haiyu Liang, Yanyan Tang, Weicong Kang +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  17. Revisiting proton therapy for adenoid cystic carcinoma: a case worth making
    Astha Rohit, Adam Holtzman, James Bates +14
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  18. A real-world nomogram integrating predictive markers for disease-free survival in postmenopausal triple-negative breast cancer receiving anthracycline/taxane-based chemotherapy
    Yan Lin, Shao-hong Yu, Chai-Ming Zeng +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  19. Imaging biomarkers related to 18F-FDG PET/CT for predicting microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis
    Zhigang Li, Ke Gong, Ning Liu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  20. IL-4 exploits TNF signaling to shape its gene expression signature in monocytes and macrophages
    Ruoxi Yuan, Chao Yang, Bikash Mishra +3
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  21. Targeting MDA5 induces immunogenic cell death and promotes anti-tumor immunity
    Zhitong Niu, Bing Cheng, Yue Jiang +16
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  22. Resistance in the edges: a relational framework for treatment resistance in genitourinary cancers
    Daniele Silva Lacerda, Rosiane Batista Mastelari, Tiago Veiras Collares
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  23. Case Report: Isolated leptomeningeal relapse after systemic control in PALB2-altered pancreatic cancer
    Jian Yuan, Yangxian Xu, Qihao Zhou +2
    Frontiers in MedicinePeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  24. Early-onset colorectal cancer burden in China from 1990 to 2023: a systematic analysis based on the Global Burden of Disease Study 2023
    Haijian Wei, Hao Wu, Shuai Wang +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  25. Cross-lagged panel analysis of kinesiophobia and frailty in older patients undergoing radical prostatectomy
    Yue Gu, Hang Liu, TingYao Nie +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC